INOS expression and NO production contribute to the direct effects of BCG on urothelial carcinoma cell biology

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 45.e1-45.e9

  Shah, Gopitkumar ^a   Zhang, Guangjian ^a   Chen, Fanghong ^a   Cao, YanLi ^a   Kalyanaraman, Balaraman ^b   See, William A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

BCG; Bladder cancer; INOS; NO

Indexed keywords

BCG VACCINE; CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; PROTEIN P21; TRANSCRIPTION FACTOR NRF2;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CARCINOMA CELL; CELL DEATH; CYTOLOGY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MTT ASSAY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION; TRANSITIONAL CELL CARCINOMA; UPREGULATION;

BCG; BLADDER CANCER; INOS; NO;

AMIDINES; BCG VACCINE; BENZYLAMINES; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CCL20; CHEMOKINE CXCL1; CHEMOKINES, CXC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 84890805014     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2013.06.005     Document Type: Article

References (25)

1. Babjuk M., Oosterlinck W., Sylvester R., et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011, 59:997-1008.
2. Kassouf W., Kamat A.M., Zlotta A., et al. Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy. Can Urol Assoc J 2010, 4:168-173.
3. Hall MC, Cheng SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer: (Stages Ta, T1, and Tis): American Urological Association. Update; 2007.
4. Oh B.R., Nakajima K., Ahn K.Y., Ryu S.B., Park Y.I., Dahiya R. Nitric oxide synthase gene and protein expression are upregulated by Bacille Calmette-Guérin in the rat bladder. Eur Urol 2001, 39:349-356.
5. Mitropoulos D., Petsis D., Kyroudi-Voulgari A., Kouloukoussa M., Zervas A., Dimopoulos C. The effect of intravesical bacillus Calmette-Guérin instillations on the expression of inducible nitric oxide synthase in humans. Nitric Oxide 2005, 13:36-41.
6. Hosseini A., Koskela L.R., Ehren I., Aguilar-Santelises M., Sirsjo A., Wiklund N.P. Enhanced formation of nitric oxide in bladder carcinoma in situ and in BCG treated bladder cancer. Nitric Oxide 2006, 15:337-343.
7. Yamada H., Matsumoto S., Matsumoto T., Yamada T., Yamashita U. Enhancing effect of an inhibitor of nitric oxide synthesis on bacillus Calmette-Guérin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro. Jpn J Cancer Res 2000, 91:534-542.
8. Pook S.H., Esuvaranathan K., Mahendran R. N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized Mycobacterium bovis in human bladder cancer cells. J Urol 2002, 168:780-785.
9. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 2004, 75:639-653.
10. Hirst D.G., Robson T. Nitric oxide physiology and pathology. Methods Mol Biol 2001, 704:1-13.
11. Kroncke K.D., Fehsel K., Suschek C., Kolb-Bachofen V. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol 2001, 1:1407-1420.
12. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J., et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997, 272:4959-4963.
13. Zhang G., Chen F., Cao Y., Amos J.V., Shah G., See W.A. HMGB1 release by urothelial carcinoma cells in response to BCG functions as a paracrine factor to potentiate the direct cellular effects of BCG. J Urol 2013, [pii: S0022-5347(13)00086-4]. 10.1016/j.juro.2013.01.050.
14. Chen F., Zhang G., Cao Y., Wakim B., See W.A. A synthetic polyvalent ligand for 51 integrin activates components of the urothelial carcinoma cell response to bacillus Calmette-Guérin. J Urol 2013, 189:1104-1109.
15. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
16. Chirino Y.I., Trujillo J., Sanchez-Gonzalez D.J., et al. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett 2009, 176:48-57.
17. Huang H., Lavoie-Lamoureux A., Moran K., Lavoie J.P. IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1147-L1154.
18. See W.A., Zhang G., Chen F., Cao Y. p21 Expression by human urothelial carcinoma cells modulates the phenotypic response to BCG. Urol Oncol 2010, 28:526-533.
19. Chakravortty D., Hensel M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect 2003, 5:621-627.
20. Rahmat J.N., Esuvaranathan K., Mahendran R. Bacillus Calmette-Guérin induces cellular reactive oxygen species and lipid peroxidation in cancer cells. Urology 2012, 79(1411):e15-e20.
21. Morcos E., Jansson O.T., Adolfsson J., Ehren I., Wiklund N.P. Bacillus Calmette-Guérin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells. J Urol 2001, 165:678-682.
22. Lodillinsky C., Langle Y., Guionet A., et al. Bacillus Calmette Guérin induces fibroblast activation both directly and through macrophages in a mouse bladder cancer model. PLoS ONE 2010, 5:e13571.
23. Alvarez V., Lodillinsky C., Umerez S., Sandes E., Eiján A.M. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment. Int J Mol Med 2005, 16:565-571.
24. Arnold J., de Boer E.C., O'Donnell M.A., Bohle A., Brandau S. Immunotherapy of experimental bladder cancer with recombinant BCG expressing interferon-gamma. J Immunother 2004, 27:116-123.
25. See W.A., Zhang G., Chen F., Cao Y., Langenstroer P., Sandlow J. Bacille-Calmette Guérin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1. BJU Int 2009, 103:1714-1720.